NATAN DAVID 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
NATAN DAVID
Director
Transactions
- Award
Common Stock
2025-01-02+100,000→ 100,000 total
Footnotes (1)
- [F1]Shares of restricted stock issued pursuant to a Director Agreement dated as of January 2, 2025 by and between Cyclacel Pharmaceuticals, Inc. and David Natan.